Shelley Fuld Nasso of NCCS Is Panelist at FDA Lung Cancer Meeting
Shelley Fuld Nasso, NCCS Senior Director of Policy, was a panelist at the June 28, 2013, Food and Drug Administration (FDA) meeting on patient-focused lung cancer drug development. Ms. Fuld Nasso offered advice to FDA about strategies for incorporating patient needs and preferences in lung cancer drug development. She concentrated her remarks on the need […]